Royalty Pharma Plc (RPRX)
55.36
+0.84
(+1.54%)
USD |
NASDAQ |
Jun 11, 15:20
Royalty Pharma SG&A Expense (Quarterly) : 159.49M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 159.49M |
| December 31, 2025 | 164.00M |
| September 30, 2025 | 118.73M |
| June 30, 2025 | 179.77M |
| March 31, 2025 | 110.70M |
| December 31, 2024 | 68.00M |
| September 30, 2024 | 56.72M |
| June 30, 2024 | 54.71M |
| March 31, 2024 | 57.65M |
| December 31, 2023 | 59.00M |
| September 30, 2023 | 57.23M |
| June 30, 2023 | 47.63M |
| March 31, 2023 | 85.70M |
| December 31, 2022 | 73.00M |
| September 30, 2022 | 50.69M |
| Date | Value |
|---|---|
| June 30, 2022 | 51.84M |
| March 31, 2022 | 51.54M |
| December 31, 2021 | 46.00M |
| September 30, 2021 | 48.59M |
| June 30, 2021 | 44.92M |
| March 31, 2021 | 43.16M |
| December 31, 2020 | 50.00M |
| September 30, 2020 | 50.73M |
| June 30, 2020 | 42.80M |
| March 31, 2020 | 38.06M |
| December 31, 2019 | 23.06M |
| September 30, 2019 | 25.60M |
| June 30, 2019 | 30.35M |
| March 31, 2019 | 24.43M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 6.034B |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Elanco Animal Health, Inc. | 381.00M |
| Harmony Biosciences Holdings, Inc. | 64.20M |